The first recorded outbreak of the virus we now call the Marburg virus occurred in 1967, Ken Alibek explains (in Biohazard), at the Behring pharmaceutical works in Marburg, an old university town seventy miles north of Frankfurt:
An animal keeper died two weeks after he contracted a mysterious illness from green monkeys sent to the Behring lab from central Africa. The lab was culturing vaccines in kidney cells extracted from the monkeys. Other workers soon fell sick, and similar cases were reported at laboratories in Frankfurt and Belgrade, both of which had received shiploads of green monkeys from central Africa at the same time.
Twenty-four lab technicians came down with the unknown disease, along with six of the nurses caring for them. Of the thirty-one people infected, seven died. This kind of undiagnosed outbreak would be alarming enough, but it was the horror of their deaths that caught the attention of biologists and tropical disease specialists around the world.
The mysterious virus appeared to liquefy body organs. One of the survivors went mad after the organism chewed away his brain cells. Before the victims died, every inch of their bodies was wet with blood.
Following tradition, the virus was named after the place where it was first identified. It would alter forever the image of a city that has been a center of European philosophy, science, and religion for centuries.
Some of the world’s greatest bacteriologists and biochemists have studied at Marburg—including Albrecht Kossel, whose research laid the groundwork for the discovery of DNA, and Alexandre Yersin, a codiscoverer of the plague bacterium (named Yersinia pestis after him). The lab in which Marburg was first smeared on a glass slide was itself named after the man credited with founding the science of immunology—Emil von Behring.
A similar virus surfaced nine years later on the banks of the Ebola River in Zaire, now the Democratic Republic of Congo. By the time that epidemic died out, 430 people were dead in Zaire and nearby Sudan.
[…]
Under an electron microscope, both organisms seemed to proliferate by shooting out tiny filament-like threads, like the lines cast by fishermen, from the cells they had already scoured for the food they needed to grow. The threads were often bent at the top, like fishing hooks, and as they prepared to invade a new cell they curled into rings, like microscopic Cheerios. Marburg and Ebola were deemed to belong to a new family of viral organisms. They were called filoviruses.
[…]
Ebola’s mortality rate is between 70 and 90 percent.
Naturally the Soviets developed weaponized versions:
A strain of Marburg arrived in the Soviet Union a decade after it was first isolated, during one of our periodic global searches for promising material. It wasn’t clear from the records whether we obtained it from the United States or directly from Germany, but it was immediately added to our growing collection of viral warfare agents. We were already investigating a number of microorganisms that weaken blood vessels and cause hemorrhagic fevers, such as Junin from Argentina and Machupo from Bolivia.
And, naturally, accidents occurred:
Ustinov had been conducting a series of experiments with guinea pigs and rabbits to monitor the effects of increasingly higher concentrations of Marburg. The injection of such a highly concentrated dose directly into his thumb meant that he now had hundreds, perhaps thousands of times more particles of the virus coursing through his body than any of the victims in Germany. I thought his chances of survival were near zero.
[…]
This was less than two years after Chernobyl; the Soviet Union was in no mood for a new disaster.
[…]
No technician should have worked long hours with such a contagious organism. People tired easily in the heavy protective suits required for Zone Three. Their reflexes slowed down, and it was easy to become careless. Adding to our problems, Marburg research had begun at Vector before a supply of antiserum was on hand.
Ustinov’s illness lasted nearly three weeks. Throughout that time, none of his colleagues was allowed to stop working.
[…]
Ustinov had been injecting Marburg into guinea pigs with the help of a lab technician, working through a glove box. He was not in a full space suit and was wearing two thin layers of rubber gloves instead of the thick mitts normally required for such work in Zone Three. The gloves provided the flexibility to control the laboratory animals, who will otherwise squirm and try to wriggle out of a technician’s grip.
Our rules required that animals targeted for injection be strapped to a wooden board to hold them securely in place. That day, Ustinov wasn’t following procedure. He decided to steady the guinea pigs with his gloved hand. Perhaps he thought it would help calm them. Or perhaps he was in too much of a hurry.
The technician became distracted and nudged him accidentally. Ustinov’s hand slipped just as he was pressing down on the syringe. The needle went through the guinea pig and punctured his thumb, drawing blood.
The needle went in no farther than half a centimeter, but the faint spot of blood indicated that liquid Marburg had entered his bloodstream. As soon as he realized what had happened, Ustinov called the duty supervisor from the telephone inside the lab.
From then on, the procedures established for such emergencies were followed to the letter. Doctors and nurses dressed in protective suits were waiting for him as he emerged from the disinfectant shower. They rushed him to the small hospital in the Vector compound, a twenty-bed isolation facility sealed off from the outside with thick walls and pressure-locked doors.
[…]
Within a couple of days he was complaining of a severe headache and nausea. Gradually, he became passive and uncommunicative, as his features froze in toxic shock. On the fourth day his eyes turned red and tiny bruises appeared all over his body: capillaries close to his skin had begun to hemorrhage.
Ustinov twitched silently in his bed while the virus multiplied in his system. Too tired to speak, or to turn over, or to eat, he would drift in and out of consciousness, staring for long periods of time at nothing. Occasionally, lucidity would return. He called for paper during those brief moments to record the progress of the virus as it foraged through his body. Sometimes he burst into tears.
On the tenth day, his fever subsided and he stopped retching. As brilliant a scientist as he was, Ustinov began to entertain the delusion that he was improving. He started smiling again and asked about his family.
[…]
By the fifteenth day, the tiny bruises on Ustinov’s body had turned dark blue, and his skin was as thin as parchment. The blood pooling underneath began oozing through. It streamed from his nose, mouth, and genitals. Through a mechanism that is still poorly understood, the virus prevents normal coagulation: the platelets responsible for clotting blood are destroyed. As the virus spreads, the body’s internal organs literally begin to melt away.
Shuddering bouts of diarrhea left rivers of black liquid on his sheets. The scraps of paper on which he had been scribbling his symptoms and which the nurses had gingerly carried out to transcribe each day no longer littered the floor. There was nothing more to write.
[…]
Each viral particle, or virion, forms a brick that pushes against the cell walls until they burst. The cells then sprout wavering hair-like antennae that home in on their next target, where the process of foraging and destruction blindly repeats itself.
[…]
The doctors from the Ministry of Health arrived early in the first week with the antiserum. To no one’s surprise, it proved useless. Antiviral drugs such as ribavirin and interferon were also tried. Hemorrhagic fevers can sometimes be treated with whole-body blood transfusions, but the medical team concluded that it would in this case be ineffective.
[…]
I don’t know how the senior levels of our bureaucracy reacted to Ustinov’s death, but no condolence letter was ever sent to his widow. Sandakchiev asked us for ten thousand rubles as special compensation for his family in addition to the normal pension survivors were entitled to. It was a princely sum in those days, and Kalinin balked at first, but he finally approved the request.
[…]
The risk of contagion made normal interment impossible, so his corpse was covered with chloramine disinfectant and wrapped in plastic sheeting. The remains were placed inside a metal box, welded shut, and fitted into a wooden coffin. Only then was it safe to lay him in the ground.
[…]
The small group of mourners included Ustinov’s immediate family, his closest colleagues, and a cordon of KGB agents who had worked frantically to keep the circumstances of his illness secret. No one came from Moscow.
Regulations prohibited the circulation of any reports about accidents, fatal or otherwise, but news of the tragedy spread quickly through The System.
[…]
A virus grown in laboratory conditions is liable to become more virulent when it passes through the live incubator of a human or an animal body. Few were surprised, therefore, when samples of Marburg taken from Ustinov’s organs after his autopsy differed slightly from the original strain. Further testing showed that the new variation was much more powerful and stable.
No one needed to debate the next step. Orders went out immediately to replace the old strain with the new, which was called, in a move that the wry Ustinov might have appreciated, “Variant U.”
[…]
After testing the weapon in explosive chambers, we applied it to the monkeys. Every one of the twelve monkeys contracted the virus. They were all dead within three weeks.
In early 1990, Marburg Variant U was ready for approval by the Ministry of Defense.
Our scientist had found it more difficult to cultivate Ebola than Marburg—they were not able to reach the necessary concentration—but by the end of 1990, the long-term problem of cultivation had been solved and we were close to developing a new Ebola weapon. Meanwhile, at Zagorsk (Sergiyev Posad) military scientists were putting the finishing touches on new Lassa fever and monkey pox biological weapons.